Evestra Inc.
Evestra, Inc. is a privately held biopharmaceutical company based in Texas, dedicated to developing innovative products in women’s healthcare and oncology. With over ten years of experience, Evestra focuses on discovery, development, and commercialization of next-generation women’s healthcare technologies and products that address unmet needs. The company operates from facilities in San Antonio and Schertz, Texas, with a strategic approach that includes establishing an attractive portfolio of women’s healthcare products, strategic collaborations, and innovative R&D in oncology.
Industries
Nr. of Employees
small (1-50)
Evestra Inc.
Products
Twice-yearly long-acting injectable contraceptive (development program)
A long-acting injectable contraceptive program intended for twice-yearly dosing, developed to expand access to modern contraception in underserved populations; program supported by grant funding.
Vaginal ring drug products (development pipeline)
Vaginal ring-based drug product projects at preclinical and clinical stages, developed using vaginal ring delivery technology and supporting GMP manufacturing.
First-in-class LIF inhibitor (preclinical oncology asset)
Preclinical oncology asset program targeting Leukemia Inhibitory Factor (LIF) for potential treatment of triple-negative breast cancer and other tumor types.
Kilo-scale steroidal API supply (offering)
Supply of kilo-scale steroidal active pharmaceutical ingredients manufactured for third-party customers and internal programs.
Twice-yearly long-acting injectable contraceptive (development program)
A long-acting injectable contraceptive program intended for twice-yearly dosing, developed to expand access to modern contraception in underserved populations; program supported by grant funding.
Vaginal ring drug products (development pipeline)
Vaginal ring-based drug product projects at preclinical and clinical stages, developed using vaginal ring delivery technology and supporting GMP manufacturing.
First-in-class LIF inhibitor (preclinical oncology asset)
Preclinical oncology asset program targeting Leukemia Inhibitory Factor (LIF) for potential treatment of triple-negative breast cancer and other tumor types.
Kilo-scale steroidal API supply (offering)
Supply of kilo-scale steroidal active pharmaceutical ingredients manufactured for third-party customers and internal programs.
Services
cGMP manufacturing of APIs and drug products
On-site manufacture of active pharmaceutical ingredients and finished drug products under cGMP and non-GMP conditions, including kilo-scale steroidal API production and vaginal ring product manufacturing.
Analytical development and testing services
Analytical method development, in-house testing and equipment to support formulation development, stability testing, and cGMP release for APIs and drug products.
Formulation and product development (vaginal rings, oral, long-acting injectables)
Formulation development for multiple dosage forms including vaginal rings and long-acting injectable contraceptives, from preclinical development through early clinical stages.
Preclinical and early clinical development support
Design and execution support for preclinical studies and Phase I/II clinical trials, including generation and publication of study data.
Business development, partnerships and grant program management
Strategic collaboration development, licensing and commercialization planning, and acquisition/management of non-dilutive funding and grants.
cGMP manufacturing of APIs and drug products
On-site manufacture of active pharmaceutical ingredients and finished drug products under cGMP and non-GMP conditions, including kilo-scale steroidal API production and vaginal ring product manufacturing.
Analytical development and testing services
Analytical method development, in-house testing and equipment to support formulation development, stability testing, and cGMP release for APIs and drug products.
Formulation and product development (vaginal rings, oral, long-acting injectables)
Formulation development for multiple dosage forms including vaginal rings and long-acting injectable contraceptives, from preclinical development through early clinical stages.
Preclinical and early clinical development support
Design and execution support for preclinical studies and Phase I/II clinical trials, including generation and publication of study data.
Business development, partnerships and grant program management
Strategic collaboration development, licensing and commercialization planning, and acquisition/management of non-dilutive funding and grants.
Expertise Areas
- Women’s health therapeutics
- Contraceptive development (long-acting injectables)
- Vaginal drug delivery and vaginal ring products
- Steroidal small-molecule medicinal chemistry
Key Technologies
- Vaginal ring drug delivery
- Long-acting injectable formulation technology
- Steroidal medicinal chemistry
- cGMP API manufacturing and scale-up